Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certification & Accreditation
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Features
AMS Features
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Association of TLR2 and TLR4 gene polymorphism with susceptibility to wart infections and their response to candida antigen immunotherapy
By
- AMS
posted
Feb 28, 2020 07:54 AM
0
Recommend
.
0 comments
0 views
Related Content
Intralesional antigen immunotherapy for warts in the era of COVID-19
- AMS
Added Aug 17, 2020
Blog Entry
‘Cryo-immuno-therapy’ is superior to intralesional Candida antigen monotherapy in the treatment of multiple common warts
- AMS
Added Feb 03, 2020
Blog Entry
Combined oral isotretinoin and Candida antigen versus either agent alone in the treatment of plane warts
- AMS
Added Apr 23, 2020
Blog Entry
Factors affecting vitiligo response to treatment: do MiRNA 196a2C/T gene polymorphism and serum tyrosinase levels have any role?
- AMS
Added Aug 25, 2020
Blog Entry
Estimating the susceptibility to SARS-CoV-2 infection with rituximab use for pemphigus vulgaris
- AMS
Added Jan 12, 2021
Blog Entry
Permalink
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic